Go to the list of all blogs
Alicia's Avatar
published in Blogs
Feb 27, 2026
Why Carter’s (CRI) Dropped -21%: A Solid Holiday Quarter Buried Under a Bleak 2026 EPS Outlook

Why Carter’s (CRI) Dropped -21%: A Solid Holiday Quarter Buried Under a Bleak 2026 EPS Outlook

Why Did Carter’s (CRI) Stock Fall Over 21% Today?

Carter’s (CRI) dropped more than 21% today because, even though it beat Q4 expectations on both sales and earnings, management issued a much weaker 2026 earnings outlook, highlighted ongoing margin pressure from tariffs and product costs, and guided to a sharp near‑term EPS drop that jarred investors.

Key Takeaways

  • Q4 2025 sales were about 925 million dollars, beating estimates and up mid‑single digits year over year (helped by an extra week), and adjusted EPS of 1.90 dollars topped the roughly 1.55–1.60 dollar consensus.

  • Despite this beat, adjusted EPS fell 20.5% from last year, and operating margin compressed by about 50 basis points to 9.2% as higher tariffs, product costs, and incentives ate into profitability.

  • For 2026, management guided to a low double‑digit to mid‑teens decline in adjusted EPS from 3.47 dollars in 2025 and forecast Q1 EPS of just 0.02–0.08 dollars versus 0.66 dollars last year, far below Wall Street expectations.

  • Higher tariffs, mix shifts, weaker cash flow (2025 operating cash flow dropped to 122 million dollars from 299 million), and lingering wholesale and retail pressures fed worries that Carter’s earnings power is structurally lower than before.

Q4 Looked Good on the Surface

Carter’s delivered a headline beat in Q4 2025. Revenue came in around 925 million dollars, up roughly 7–8% year over year and above consensus near 904 million dollars, with growth across U.S. retail, international, and wholesale. Part of that growth reflected a 53rd week in the fiscal year, which management said added about 37 million dollars of sales, so underlying growth was closer to 3–4%.

Adjusted EPS was 1.90 dollars, handily beating expectations of roughly 1.55–1.60 dollars. Operating income ticked up about 1.8% to roughly 84.7 million dollars, but the operating margin slipped to 9.2% from 9.7% as the company absorbed higher input costs and tariffs. On a full‑year basis, revenue rose to about 2.9 billion dollars, yet GAAP diluted EPS dropped to 2.53 dollars from 5.12, and adjusted EPS fell to 3.47 dollars, underscoring how much profitability has compressed even as sales held up.

Guidance Shock: 2026 EPS Set to Fall

The real problem was what Carter’s said about the future. Management guided 2026 adjusted EPS to about 2.91 dollars, implying a low double‑digit to mid‑teens percentage decline from 3.47 dollars in 2025, even though they expect low‑ to mid‑single‑digit net sales growth. In practical terms, that means revenue may inch up, but rising costs and tariffs will continue to squeeze profits.

The near‑term outlook was even more jarring. For Q1 2026, Carter’s projected adjusted EPS of just 0.02–0.08 dollars, compared with 0.66 dollars in the prior‑year quarter and consensus near 0.36 dollars—one of the largest negative EPS guide gaps in the consumer space this season. Management cited higher tariffs, elevated product costs as they invest in product “make,” promotional intensity, and deleverage in both U.S. retail and wholesale as key headwinds.

Investors had already been wrestling with conflicting analyst views: some saw Carter’s as a value play, while others warned that longer‑term forecasts point to flat‑to‑down revenue and significantly lower earnings by 2028. Today’s guidance effectively endorsed the more pessimistic camp, confirming that margin and EPS pressures are not just a 2025 blip.

Margin Pressure, Tariffs, and Weak Cash Flow

Beyond EPS guidance, several underlying trends raised red flags. Adjusted operating income for 2025 fell by about 26 million dollars, and the adjusted operating margin dropped from roughly 13.4% to 9.7%, driven largely by lower profitability in U.S. retail and wholesale segments. Management highlighted the “lion’s share” of the decline came from higher tariffs and product costs, along with wage and incentive pressures.

Cash flow also deteriorated meaningfully. Operating cash flow fell to roughly 122 million dollars in 2025 from about 299 million dollars the year before, mainly due to higher inventories and reduced earnings. That weaker cash generation, combined with refinancing activity and a new 750‑million‑dollar asset‑based revolver, reinforced the sense that Carter’s is operating with less financial flexibility than in the past.

Although management is executing productivity actions—cutting about 300 office jobs, planning roughly 150 store closures over three years, and targeting 35 million dollars in annual savings plus more than 10 million dollars in SG&A cuts—those benefits will take time to fully materialize and may be partially offset by ongoing cost and tariff headwinds.

Why the Stock Fell Over 21% Today

When you combine a Q4 beat with:

  • 20% year‑over‑year drop in adjusted EPS,

  • A big decline in operating and cash‑flow margins, and

  • A 2026 EPS outlook that calls for another low‑teens percentage decline,

you get a classic “good quarter, bad future” setup.

Traders quickly repriced CRI to reflect structurally lower earnings power. The stock slid from the mid‑40s into the low‑30s, a drop of more than 20%, putting it near its 52‑week lows despite what appears, at first glance, to be solid holiday‑quarter results. In short, Carter’s didn’t fall because Q4 was weak; it fell because management confirmed that profits are likely to keep shrinking in 2026, and the market is no longer willing to ignore that reality.

Tickeron AI Perspective

 Disclaimers and Limitations

Related Ticker: CRI

Contributor

Alicia's AvatarAlicia|Beginner

CRI in downward trend: 10-day moving average broke below 50-day moving average on July 20, 2026

The 10-day moving average for CRI crossed bearishly below the 50-day moving average on July 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRI as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CRI turned negative on August 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

CRI moved below its 50-day moving average on August 11, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRI entered a downward trend on August 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRI advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.278) is normal, around the industry mean (3.515). P/E Ratio (6.674) is within average values for comparable stocks, (22.291). CRI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.839). Dividend Yield (0.028) settles around the average of (0.033) among similar stocks. P/S Ratio (0.426) is also within normal values, averaging (0.748).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are TJX Companies (NYSE:TJX), lululemon athletica (NASDAQ:LULU), Gap Inc (The) (NYSE:GAP), Abercrombie & Fitch Co (NYSE:ANF), Stitch Fix (NASDAQ:SFIX).

Industry description

Companies in the apparel and/or footwear retail industry sell clothing, accessories and footwear, for different age groups and genders. The industry’s product categories could range from basics, such as underwear, to luxury items. Some retailers source items from wholesalers or an apparel brand to sell in their stores; some others are licensed to make and market their own retail goods under particular brands. Several companies outsource production of clothing to developing/emerging economies where labor costs are relatively inexpensive. Apparel retail is often influenced by fashion trends, and many companies feel the need to adapt to what’s “in vogue” to retain customers and attract new ones. A major disruption in this industry has been the burgeoning trend in digital shopping – to compete with rapidly growing e-commerce, even traditional retail players are upping the ante on their online platforms. Much of the products’ performance in apparel/footwear retail is cyclical, i.e., economic boom times encourage consumer spending, while recessions induce thriftiness among people. Some large-cap U.S. apparel/footwear retail companies include TJX Companies Inc., Ross Stores, Inc., Lululemon Athletica Inc. and Burlington Stores, Inc.

Market Cap

The average market capitalization across the Apparel/Footwear Retail Industry is 9.32B. The market cap for tickers in the group ranges from 256K to 179.95B. IDEXY holds the highest valuation in this group at 179.95B. The lowest valued company is DESTQ at 256K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Retail Industry was -4%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -2%. RENT experienced the highest price growth at 8%, while DBGI experienced the biggest fall at -42%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Retail Industry was 59%. For the same stocks of the Industry, the average monthly volume growth was 36% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 44
P/E Growth Rating: 50
Price Growth Rating: 56
SMR Rating: 66
Profit Risk Rating: 87
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
CRI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of apparel and related products for babies and young children

Industry ApparelFootwearRetail

Profile
Details
Industry
Apparel Or Footwear Retail
Address
3438 Peachtree Road North East
Phone
+1 678 791-1000
Employees
15230
Web
https://www.carters.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.